MicroPort® Attends the 2019 World Health Expo

Wuhan, China – The first edition of World Health Expo (“the Expo”) was held at the Wuhan International Expo Center recently. The Expo was guided by the National Health Committee of China and the People's Government of Hubei Province, and hosted by the Wuhan Municipal People's Government. With a theme of “A Healthy Future Driven by Science and Technology,” the Expo aimed to address the future development trend of the healthcare industry and feature the most cutting-edge healthcare science and technology as well as most representative healthcare corporations, products and business models. The Expo attracted over 4,000 exhibitors and over 200,000 visitors. Shanghai MicroPort Medical (Group) Co., Ltd. (“MicroPort®”) presented at the Expo over 60 innovative products in the fields of cardiovascular intervention, orthopedics, cardiac rhythm management, structural heart diseases, neurovascular intervention, diabetics and endocrine diseases, and rehabilitation, which attracted huge attention.

The Expo contained an approximate 100 high-end forums and was attended by political leaders from the “Belt and Road” countries, world-renowned Nobel Prize laureates, academicians and healthcare experts and scholars, major leaders from state ministries, provinces and municipalities, and healthcare professionals from the hospitals affiliated to the Wuhan Municipal People's Government and from provincial and municipal medical insurance authorities. The joint MicroPort® booth was a focal point of visits, consultation and exchanges from the leaders and experts attending the Expo. Local news outlets took great interest in and covered the independently developed key products of MicroPort®, such as Firehawk® Rapamycin Target Eluting Coronary Stent System, Firebird2® Rapamycin-Eluting Coronary CoCr Stent System, Rega® Family Implantable Pacemakers, EVOLUTION® Medial-Pivot Total Knee Replacement System and SuperPath® Supercapsular Percutaneously Assisted Total Hip Arthroplasty.

The Summit Forum on Opportunity and Challenge of Medical Reform was held during the Expo. With a theme of “New Era, New Policy, New Challenge, New Opportunity”, the Summit Forum brought together speakers from governments, academia and the healthcare industry to focus on the trend of policy changes in medical reform from different levels and perspectives. The MicroPort® senior executives, including Liping Wang, Senior Director, Domestic Emerging Market Development and Education, attended the Summit Forum to discuss with the experts and scholars how the healthcare companies should meet the challenges and snap up opportunities amid the trends of supply side reform and high-quality development in China.

The report from the 19th National Congress of the Communist Party of China stated that the Healthy China Strategy is a major aspect of the country’s national fundamental development strategy. The healthcare industry has become the most promising sector in China. As a leading innovation-driven high-end medical device group in China, MicroPort® follows a management credo of “Eyes from Greatness, Hands on Details”. MicroPort® is people-centric and bent on innovation to commit to providing more high-quality medical device products and therapeutic solutions to promote the organic connection, positive interaction and sustainable development of China’s healthcare industry and healthcare cause.